Diabetes Kongress 2020
zur Liste
Dr. Jörg Bäumler
Lilly Deutschland GmbH Germany
  • Vortrag Chronic Kidney Disease (CKD) Outcomes With Dulaglutide (DU) Versus Insulin Glargine (IG) in Type 2 Diabetes (T2D) and Moderate-to-Severe CKD by Albuminuria Status: AWARD-7 Speaker
    Datum: 22.05.2020 , Zeit: 09:58 | Thema: Poster
    Details